Advertisement
Advertisement
CRNX
Crinetics Pharmaceuticals, Inc.
37.48
USDSponsored
-6.01
-13.82%
May 08, 16:00 UTC -4
Closed
After-Market
36.75
-0.73
-1.95%
Crinetics Pharmaceuticals, Inc. Financial Snapshot
| Market Cap | 3.87B |
| Beta | 0.30 |
| Earnings Per Share (EPS) | -4.94 |
| Price-to-Book (P/B) Ratio | 4.08 |
| Operating Margin | -6046.22% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -41.46% |
| Current Ratio | 12.32% |
| Free Cash Flow | -383.68M |
Trending Stocks
Advertisement